Literature DB >> 17251215

Management of complex regional pain syndrome type II using lidoderm 5% patches.

A Karmarkar1, I Lieberman.   

Abstract

We report a case of a patient developing complex regional pain syndrome of the upper limb after a laceration injury with glass. The pain in his hand was resistant to all conventional modes of treatment. The pain reduced dramatically after a diagnostic lidocaine infusion and the reduction in pain lasted for 3 days. Following this the patient responded well to lidoderm 5% patches and achieved 80% pain relief with an improved range of movement in his hand.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251215     DOI: 10.1093/bja/ael343

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  [Lidocaine patch for therapy of neuropathic and non-neuropathic pain. A clinical case series of 87 patients].

Authors:  K-U Kern; M Kohl; R T Kiefer
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

2.  Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.

Authors:  Julia Ann Fleming; Bradley David O'Connor
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

3.  Reduction in mechanical allodynia in complex regional pain syndrome patients with ultrasound-guided pulsed radiofrequency treatment of the superficial peroneal nerve.

Authors:  Won Soek Chae; Sang Hyun Kim; Sung Hwan Cho; Joon Ho Lee; Mi Sun Lee
Journal:  Korean J Pain       Date:  2016-09-29

4.  5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions.

Authors:  Enrique Calderón; María Eloísa Calderón-Seoane; Rafael García-Hernández; Luis Miguel Torres
Journal:  J Pain Res       Date:  2016-10-06       Impact factor: 3.133

5.  Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?

Authors:  Kai-Uwe Kern; Srinivas Nalamachu; Louis Brasseur; Joanna M Zakrzewska
Journal:  J Pain Res       Date:  2013-04-05       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.